Security key
81728A108
- Security type / class
- Equity / COM
- Total 13F shares
- 2,962,310
- Total 13F value
- $2,049,732
- Share change
- -161,796
- SEC-reported price per share
- $0.69
- Number of holders
- 23
- Value change
- -$112,090
- Number of buys
- 4
- Number of sells
- 7
Report period
Q4 2023
Institutions
23
Top holders
10
SNSE full security history
Ownership snapshot
Full 13F holder table
Faeth Therapeutics, Inc. SEC filings
Faeth Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of SNSE - Sensei Biotherapeutics, Inc. - COM (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Newtyn Management, LLC
Disclosed value leader
Newtyn Management, LLC
Comparable rows
0/15
Latest evidence
30 Sep 2023
13F
3/4/5
Highest disclosed value: $1,350,180
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Newtyn Management, LLC has the largest disclosed position value at $1.35M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Newtyn Management, LLC's linked filing trail.
Disclosed position value
Top 5
Newtyn Management, LLC
$1.35M
VANGUARD GROUP INC
$458.9K
GEODE CAPITAL MANAGEMENT, LLC
$102.3K
BRIDGEWAY CAPITAL MANAGEMENT, LLC
$84.7K
Robert Hamilton Pierce
$80.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Newtyn Management, LLC |
13F
Company
|
—
class O/S missing
|
$1,350,180
1,800,000 shares
|
— | 30 Sep 2023 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$458,921
573,651 shares
|
— | 30 Sep 2023 |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$102,274
136,318 shares
|
— | 30 Sep 2023 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
Company
|
—
class O/S missing
|
$84,686
112,900 shares
|
— | 30 Sep 2023 |
| Robert Hamilton Pierce |
3/4/5
Chief R&D Officer
|
—
class O/S missing
|
$80,294
94,463 shares
|
— | 15 Feb 2022 |
| Duquesne Family Office LLC |
13F
Company
|
—
class O/S missing
|
$80,000
100,000 shares
|
— | 30 Sep 2023 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2023
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
23
Shares
2,962,310
Rows available
23
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2023 vs Q3 2023 Across Filers
Q3 2023 holders
22
Q4 2023 holders
23
Holder diff
1
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|